FHTX FY 2019 Earnings — Foghorn Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

FHTXFoghorn Therapeutics Inc.

$322M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$51M

Net Income

-$51M

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$47M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$22M

Total Liabilities

$110M

Stockholders' Equity

-$88M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$379,000	-373.1%
Operating Income	-$51M	-$26M	-96.1%
Net Income	-$51M	-$26M	-94.1%